Experience

Davis Polk advised the sales agents in connection with certain amendments of the SEC-registered at-the-market offering program by Millendo Therapeutics, Inc. of up to $50 million gross…

Davis Polk advised MSCI Inc. in connection with a Rule 144A/Regulation S offering of $400 million aggregate principal amount of its 3.625% senior notes due 2030. The notes are guaranteed by…

Davis Polk is advising J M Smith Corporation in connection with the sale of its technologies division, Smith Technologies, to private equity sponsor Francisco Partners, pursuant to a…

Davis Polk is advising Mobile Mini, Inc. on its all-stock merger of equals with WillScot Corporation to form a combined company with an implied total enterprise value of approximately $6.6…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by NuVasive, Inc. of $450 million aggregate principal amount of its 0.375% convertible senior notes due…

Davis Polk advised the sales agents in connection with an SEC-registered at-the-market offering by Tellurian Inc. of its shares of common stock having an aggregate offering price of up…

Davis Polk advised the initial purchasers in connection with a Regulation S offering by Zhenro Properties Group Limited of $200 million 5.6% senior notes due 2021. Zhenro Properties Group…

Davis Polk advised the sales agent on the SEC-registered at-the-market offering by Atara Biotherapeutics, Inc. of its common stock for up to an aggregate amount of $100 million. Based in…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Bandwidth Inc. of an aggregate principal amount of $400 million of its 0.25% convertible senior…

Davis Polk advised the sales agent in connection with the SEC-registered at-the-market offering by CytomX Therapeutics, Inc. of its common stock for up to an aggregate amount of $75 million…